These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18931916)

  • 1. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.
    Maguire-Zeiss KA; Federoff HJ
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):298-308. PubMed ID: 18931916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy as a therapeutic treatment for neurodegenerative disorders.
    White AR; Hawke SH
    J Neurochem; 2003 Nov; 87(4):801-8. PubMed ID: 14622111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy: An emerging treatment option for neurodegenerative diseases.
    Mukherjee A; Biswas S; Roy I
    Drug Discov Today; 2024 May; 29(5):103974. PubMed ID: 38555032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Parkinson's disease.
    Schwab AD; Thurston MJ; Machhi J; Olson KE; Namminga KL; Gendelman HE; Mosley RL
    Neurobiol Dis; 2020 Apr; 137():104760. PubMed ID: 31978602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrabody applications in neurological disorders: progress and future prospects.
    Miller TW; Messer A
    Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for conformational diseases.
    Sigurdsson EM
    Curr Pharm Des; 2006; 12(20):2569-85. PubMed ID: 16842179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization as treatment for Parkinson's disease.
    Agbo DB; Neff F; Seitz F; Binder C; Oertel WH; Bacher M; Dodel R
    J Neural Transm Suppl; 2009; (73):311-5. PubMed ID: 20411789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy].
    Litvinenko IV; Krasakov IV; Bisaga GN; Skulyabin DI; Poltavsky ID
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):3-10. PubMed ID: 28980606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer.
    Vana K; Zuber C; Pflanz H; Kolodziejczak D; Zemora G; Bergmann AK; Weiss S
    Infect Disord Drug Targets; 2009 Feb; 9(1):69-80. PubMed ID: 19200017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.
    Brazier MW; Mot AI; White AR; Collins SJ
    Ther Deliv; 2013 May; 4(5):615-28. PubMed ID: 23647278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseases.
    Messer A; McLear J
    BioDrugs; 2006; 20(6):327-33. PubMed ID: 17176119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene- and cell-based approaches for neurodegenerative disease.
    Urbaniak Hunter K; Yarbrough C; Ciacci J
    Adv Exp Med Biol; 2010; 671():117-30. PubMed ID: 20455500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common therapeutic strategies for prion and Alzheimer's diseases.
    Elezgarai SR; Biasini E
    Biol Chem; 2016 Nov; 397(11):1115-1124. PubMed ID: 27279060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for B lymphocytes in anti-infective prion therapies?
    Tayebi M; Bate C; Hawke S; Williams A
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):631-8. PubMed ID: 17678426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.